Standard BioTools Inc. develops, manufactures, and sells technologies that help biomedical researchers in their search for developing medicines. The Company's segments include Proteomics and Genomics. The Proteomics segment includes its instruments, consumables, software, and services based upon technologies used in the identification of proteins. The Genomics segment includes its instruments, consumables, software, and services based upon technologies used in the identification of genes and their functions. The Company provides insights in health and disease using its mass cytometry and microfluidics technologies, which serve applications in proteomics and genomic. It works with academic, government, pharmaceutical, biotechnology, plant and animal research, and clinical laboratories around the world, focusing on the needs in translational and clinical research, including oncology, immunology, and immunotherapy. The Company also provides differentiated multi-omics tools for research.
Mã chứng khoánLAB
Tên công tyStandard BioTools Inc
Ngày IPOFeb 10, 2011
Giám đốc điều hànhDr. Michael Egholm, Ph.D.
Số lượng nhân viên818
Loại chứng khoánOrdinary Share
Kết thúc năm tài chínhFeb 10
Địa chỉ2 Tower Place
Thành phốSOUTH SAN FRANCISCO
Sàn giao dịch chứng khoánNASDAQ Global Select Consolidated
Quốc giaUnited States of America
Mã bưu điện94080
Điện thoại16502666000
Trang webhttps://www.standardbio.com/
Mã chứng khoánLAB
Ngày IPOFeb 10, 2011
Giám đốc điều hànhDr. Michael Egholm, Ph.D.
Tổng cộng
0.00
USD đã được phân phối dưới dạng cổ tức trong 5 năm qua.

Không có dữ liệu